The intriguing roles of Siglec family members in the tumor microenvironment.
Kui-Ying JiangLi-Li QiFu-Biao KangLing WangPublished in: Biomarker research (2022)
Sialic acid-binding receptors are expressed on the surfaces of a variety of immune cells and have complex and diverse immunoregulatory functions in health and diseases. Recent studies have shown that Siglecs could play diverse immune and nonimmune regulatory roles in the tumor microenvironment (TME) and participate in tumor progression through various mechanisms, such as regulating tumor growth and metastasis, mediating the inflammatory response, and promoting tumor immune escape, thereby affecting the prognoses and outcomes of patients. However, depending on the cell type in which they are expressed, each Siglec member binds to corresponding ligands in the microenvironment milieu to drive diverse cell physiological and pathological processes in tumors. Therefore, we herein summarize the expression spectra and functions of the Siglec family in human diseases, particularly cancer, and highlight the possibility of therapeutic interventions targeting the TME in the future.
Keyphrases
- inflammatory response
- poor prognosis
- end stage renal disease
- endothelial cells
- healthcare
- chronic kidney disease
- stem cells
- public health
- single cell
- physical activity
- papillary thyroid
- mental health
- type diabetes
- binding protein
- cell therapy
- long non coding rna
- health information
- lipopolysaccharide induced
- cancer therapy
- current status
- escherichia coli
- immune response
- squamous cell
- dna binding
- pseudomonas aeruginosa
- density functional theory
- patient reported
- lymph node metastasis
- molecular dynamics
- glycemic control